A phase II trial of LEE011 in combination with everolimus in the treatment of advanced well differentiated neuroendocrine tumors of foregut origin Meeting Abstract
| Authors: | Raj, N. P.; Kelly, V.; Chan, J. A.; Dasari, A.; Capanu, M.; Tang, L.; Reidy, D. L. |
| Abstract Title: | A phase II trial of LEE011 in combination with everolimus in the treatment of advanced well differentiated neuroendocrine tumors of foregut origin |
| Meeting Title: | 2018 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2018 Jan 18-20 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-02-01 |
| Language: | English |
| ACCESSION: | WOS:000436174100526 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2018.36.4_suppl.TPS546 |
| Notes: | Meeting Abstract: TPS546 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
